Epithelial Barrier During Corneal Infection
角膜感染期间的上皮屏障
基本信息
- 批准号:6525371
- 负责人:
- 金额:$ 28.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-30 至 2005-08-31
- 项目状态:已结题
- 来源:
- 关键词:CD14 molecule Pseudomonas aeruginosa bacteria infection mechanism biological signal transduction cell component structure /function confocal scanning microscopy cornea corneal epithelium enzyme activity enzyme inhibitors eye infections flow cytometry gel mobility shift assay human tissue immunofluorescence technique immunoprecipitation keratitis lipopolysaccharides mitogen activated protein kinase neutralizing antibody nuclear factor kappa beta organ culture phosphorylation swine tight junctions western blottings
项目摘要
DESCRIPTION (provided by applicant): The long-term goal of this application is
to understand the mechanisms underlying the induction of the inflammatory
reaction and breakdown of the epithelial barrier in the cornea upon infection.
Recent data has shown that challenging human corneal epithelial (HCE) cells
with lipopolysaccharide (LPS) isolated from Pseudomonas aeruginosa (PA), a
major cause of bacterial keratitis, increases monolayer permeability and
alteration of tight junction (TJ) status. LPS and PA challenges also lead to
activation of NF-kappaB, a transcription factor activated by Toll-like receptor
4 (TLR4, the predominant LPS receptor in mammals). Furthermore, PA infection
resulted in the loss of epithelial barrier function in cultured pig corneas.
The current application will test the hypothesis that in the cornea TLRs confer
responsiveness of HCE cells to pathogens, and PA challenge-induced TLR
signaling, through activation of NF-kappaB and/or mitogen-activated protein
kinase (MAPK), contributes to infection-induced epithelial barrier breakdown.
The following studies will be carried out. (1) Alterations of barrier
properties in corneal epithelial cells upon PA infection will be assessed using
HCE cells cultured on Transwell filters as a model epitheliuin. Parameters to
be measured include transepithelial electrical resistance, and paracellular
flux, alterations in TJ proteins ZO-1 and ZO-2. (2) Signal transduction
pathway(s) that couples PA challenge to alteration of epithelial barrier
function in HCE cells will be characterized using antibodies to detect cell
surface expression of TLRs and co-receptor CD 14, and pharmacological reagents
to inhibit activation of NF-kappaB and MAPK upon HCE cell infection. (3)
Whether infection-induced epithelial responses, including barrier breakdown,
can be inhibited by modification of TLR-mediated signaling will be assessed. A
combination of transfection of TLRs and their mutants and the neutralizing
antibodies will be used to assess epithelial response to PA challenge in
Transwell model epithelium. TLR neutralizing antibodies, along with other
biological and pharmacological reagents, will also be applied to corneal organ
culture to determine if infection-induced epithelial responses and barrier
breakdown can be inhibited. An understanding of how TLRs transmit signals that
lead to epithelial responses, including modulation of barrier function, may
allow the development of therapeutic agents that prevent breakdown or enhance
recovery of barrier function during infection and, as an adjuvant therapy,
eliminate the corneal scarring and vision loss associated with bacterial
keratitis.
描述(由申请人提供):本申请的长期目标是
为了了解炎症诱导的潜在机制,
感染后角膜上皮屏障的反应和破坏。
最近的数据表明,具有挑战性的人角膜上皮(HCE)细胞
与从铜绿假单胞菌(PA)分离的脂多糖(LPS),a
细菌性角膜炎的主要原因,增加单层通透性,
紧密连接(TJ)状态的改变。LPS和PA挑战还导致
Toll样受体激活的转录因子NF-κ B的激活
4(TLR 4,哺乳动物中的主要LPS受体)。此外,PA感染
导致培养的猪角膜上皮屏障功能丧失。
本申请将测试在角膜中TLR赋予角膜细胞增殖的假设。
HCE细胞对病原体的反应性和PA激发诱导的TLR
通过NF-κ B和/或促分裂原活化蛋白的活化进行信号传导
丝裂原活化蛋白激酶(MAPK)参与感染诱导的上皮屏障破坏。
将开展以下研究。(1)屏障改建
PA感染后角膜上皮细胞的特性将使用
HCE细胞在Transwell滤膜上培养作为模型上皮细胞。参数以
包括跨上皮电阻和细胞旁电阻。
流量,TJ蛋白ZO-1和ZO-2的改变。(2)信号转导
将PA激发与上皮屏障改变偶联的途径
HCE细胞中的功能将使用抗体来检测细胞
TLR和共受体CD 14的表面表达,以及药理学试剂
抑制HCE细胞感染后NF-κ B和MAPK的活化。(三)
感染诱导的上皮反应,包括屏障破坏,
可以通过TLR介导的信号传导的修饰来抑制。一
TLR及其突变体的转染和中和的组合
抗体将用于评估上皮细胞对PA激发的反应,
Transwell模型上皮。TLR中和抗体,沿着其他
生物和药理试剂也将应用于角膜器官
培养以确定感染诱导的上皮反应和屏障
可以抑制击穿。了解TLR如何传递信号,
导致上皮反应,包括调节屏障功能,可以
允许开发防止分解或增强的治疗剂,
在感染期间恢复屏障功能,作为辅助治疗,
消除与细菌性角膜炎相关的角膜瘢痕和视力丧失
角膜炎。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Fu-Shin X Yu其他文献
Fu-Shin X Yu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Fu-Shin X Yu', 18)}}的其他基金
Mechanisms of flagellin-induced protection against microbial keratitis
鞭毛蛋白诱导的微生物性角膜炎保护机制
- 批准号:
8248480 - 财政年份:2008
- 资助金额:
$ 28.7万 - 项目类别:
Mechanisms of flagellin induced protection against bacterial keratitis
鞭毛蛋白诱导预防细菌性角膜炎的机制
- 批准号:
7923002 - 财政年份:2008
- 资助金额:
$ 28.7万 - 项目类别:
Mechanisms of flagellin induced protection against bacterial keratitis
鞭毛蛋白诱导预防细菌性角膜炎的机制
- 批准号:
7844845 - 财政年份:2008
- 资助金额:
$ 28.7万 - 项目类别:
Mechanisms of flagellin-induced protection against microbial keratitis
鞭毛蛋白诱导的微生物性角膜炎保护机制
- 批准号:
8655872 - 财政年份:2008
- 资助金额:
$ 28.7万 - 项目类别:
Mechanisms of flagellin induced protection against bacterial keratitis
鞭毛蛋白诱导预防细菌性角膜炎的机制
- 批准号:
7615662 - 财政年份:2008
- 资助金额:
$ 28.7万 - 项目类别:
Mechanisms of flagellin induced protection against bacterial keratitis
鞭毛蛋白诱导预防细菌性角膜炎的机制
- 批准号:
8332413 - 财政年份:2008
- 资助金额:
$ 28.7万 - 项目类别:
Mechanisms of flagellin-induced protection against microbial keratitis
鞭毛蛋白诱导的微生物性角膜炎保护机制
- 批准号:
8840592 - 财政年份:2008
- 资助金额:
$ 28.7万 - 项目类别:
Mechanisms of flagellin induced protection against bacterial keratitis
鞭毛蛋白诱导预防细菌性角膜炎的机制
- 批准号:
7461874 - 财政年份:2008
- 资助金额:
$ 28.7万 - 项目类别:
Mechanisms of flagellin-induced protection against microbial keratitis
鞭毛蛋白诱导的微生物性角膜炎保护机制
- 批准号:
8445213 - 财政年份:2008
- 资助金额:
$ 28.7万 - 项目类别:
相似国自然基金
生物质炭负载噬菌体对土壤中抗生素耐药菌(Pseudomonas aeruginosa)迁移阻控及靶向裂解的协同机制
- 批准号:
- 批准年份:2020
- 资助金额:57 万元
- 项目类别:面上项目
融合自组装双亲短肽提高Pseudomonas aeruginosa脂肪氧合酶热稳定性机制的研究
- 批准号:31401638
- 批准年份:2014
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
铜绿假单胞菌(Pseudomonas aeruginosa)SU8抑菌活性物质吩嗪-1-甲酰胺结构改造及增效作用研究
- 批准号:31301709
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
铜绿假单胞菌(Pseudomonas aeruginosa)作用下PBS及其共聚物的降解途径研究
- 批准号:21144008
- 批准年份:2011
- 资助金额:10.0 万元
- 项目类别:专项基金项目
Pseudomonas aeruginosa长链烷烃羟化酶基因的研究
- 批准号:30870081
- 批准年份:2008
- 资助金额:30.0 万元
- 项目类别:面上项目
相似海外基金
CAREER: A Multi-phase Biosensing Approach towards Point-of-Care Evaluation of Pseudomonas aeruginosa Virulence in Infected Chronic Wounds
职业生涯:用于护理点评估慢性感染伤口中铜绿假单胞菌毒力的多阶段生物传感方法
- 批准号:
2340867 - 财政年份:2024
- 资助金额:
$ 28.7万 - 项目类别:
Continuing Grant
Rapid detection of Pseudomonas aeruginosa in people with cystic fibrosis
快速检测囊性纤维化患者中的铜绿假单胞菌
- 批准号:
10103495 - 财政年份:2024
- 资助金额:
$ 28.7万 - 项目类别:
Collaborative R&D
Use of Opsonophagocytic Assay for Serological Evaluation of SimCell vaccines against Pseudomonas aeruginosa infection
使用调理吞噬试验对针对铜绿假单胞菌感染的 SimCell 疫苗进行血清学评估
- 批准号:
10108204 - 财政年份:2024
- 资助金额:
$ 28.7万 - 项目类别:
Collaborative R&D
Regulation of the virulence factor PlcH in Pseudomonas aeruginosa
铜绿假单胞菌毒力因子PlcH的调控
- 批准号:
10884588 - 财政年份:2023
- 资助金额:
$ 28.7万 - 项目类别:
Exploiting Pf phage superinfection to lower Pseudomonas aeruginosa virulence via evolutionary tradeoffs
利用 Pf 噬菌体重复感染通过进化权衡降低铜绿假单胞菌毒力
- 批准号:
10748681 - 财政年份:2023
- 资助金额:
$ 28.7万 - 项目类别:
Molecular Mechanisms of Pseudomonas aeruginosa Antibiotic Persistence in Monocultures and Microbial Communities
单一栽培和微生物群落中铜绿假单胞菌抗生素持久性的分子机制
- 批准号:
10749974 - 财政年份:2023
- 资助金额:
$ 28.7万 - 项目类别:
The role of master regulator NtrC in amyloid fibril dependent pathogenic traits of Pseudomonas aeruginosa
主调节因子 NtrC 在铜绿假单胞菌淀粉样原纤维依赖性致病性状中的作用
- 批准号:
10990786 - 财政年份:2023
- 资助金额:
$ 28.7万 - 项目类别:
Characterisation of autolytic programmed cell death in Pseudomonas aeruginosa biofilms
铜绿假单胞菌生物膜中自溶程序性细胞死亡的表征
- 批准号:
BB/X008436/1 - 财政年份:2023
- 资助金额:
$ 28.7万 - 项目类别:
Research Grant
Study of clinically over-expressed and chimeric RND multidrug efflux pumps from Acinetobacter baumannii and Pseudomonas aeruginosa
鲍曼不动杆菌和铜绿假单胞菌临床过表达和嵌合 RND 多药外排泵的研究
- 批准号:
23K14346 - 财政年份:2023
- 资助金额:
$ 28.7万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Monoclonal Antibody to Combat Pseudomonas Aeruginosa
对抗铜绿假单胞菌的单克隆抗体
- 批准号:
10674274 - 财政年份:2023
- 资助金额:
$ 28.7万 - 项目类别:














{{item.name}}会员




